Your search:
3088 result(s) in 2.77 s (only 2000 displayed)
-
DUK10163226_007
Herzerkrankung von den Doktoren übersehen: Dan Cipriani konnte dank seiner neuen Smartwatch selbst eine supraventrikuläre Tachykardie diagnostizieren
SONDERKONDITIONEN: Satzpreis!
WORDS BYLINE: Sarah Ingram
The symptoms were scary. Dan Cipriani’s heart rate would speed up and he would feel lightheaded and dizzy - sometimes while exercising and at others while he was at rest.
Dan first went to the doctor when he was 13 with sudden random onset palpitations, but he left the GP’s office without answers.
Dan went back another five times over the years and always left with doctors scratching their heads.
He was given a battery of tests; wearing a heart monitor for days on end or booking into hospital for echocardiograms and ECGs - but nothing was conclusive.
Meanwhile, the episodes kept happening. Dan’s heart rate would reach 220 BPM while sitting down; when it should have been between 60 and 100.
The 32-year-old banking director from London has always been fitness-mad.
He has run countless sub-three hour marathons, three ultra marathons including one 100-mile race and has competed in an Ironman.
He could not be healthier, but each time he would exercise, he would experience these troubling episodes.
‘They happened probably once a fortnight but then became more frequent over the last two years and would last longer, perhaps up to a minute,’ he says.
‘They also always happened during intense exercise. I did an Ironman triathlon and the London Marathon, and my heart rate jumped up to 220 beats a minute during the races, which was scary. I’ve had different diagnoses from stress with my work to potentially low blood sugar’, he explains.
Then, a year ago, he was finally given a diagnosis. After an event where his heart raced constantly at 220BPM, he decided he’d had enough and went back to his cardiologist and demanded answers.
‘My doctor told me to buy a Kardia monitor, which is an ECG device you attach to your phone so you can track a cardiac event when it happens. The day after I bought it, I had an episode and caught it with the monitor, sent it to my cardiologist, and he knew immediately what it w *** Lo
(c) Dukas -
DUK10163226_004
Herzerkrankung von den Doktoren übersehen: Dan Cipriani konnte dank seiner neuen Smartwatch selbst eine supraventrikuläre Tachykardie diagnostizieren
SONDERKONDITIONEN: Satzpreis!
WORDS BYLINE: Sarah Ingram
The symptoms were scary. Dan Cipriani’s heart rate would speed up and he would feel lightheaded and dizzy - sometimes while exercising and at others while he was at rest.
Dan first went to the doctor when he was 13 with sudden random onset palpitations, but he left the GP’s office without answers.
Dan went back another five times over the years and always left with doctors scratching their heads.
He was given a battery of tests; wearing a heart monitor for days on end or booking into hospital for echocardiograms and ECGs - but nothing was conclusive.
Meanwhile, the episodes kept happening. Dan’s heart rate would reach 220 BPM while sitting down; when it should have been between 60 and 100.
The 32-year-old banking director from London has always been fitness-mad.
He has run countless sub-three hour marathons, three ultra marathons including one 100-mile race and has competed in an Ironman.
He could not be healthier, but each time he would exercise, he would experience these troubling episodes.
‘They happened probably once a fortnight but then became more frequent over the last two years and would last longer, perhaps up to a minute,’ he says.
‘They also always happened during intense exercise. I did an Ironman triathlon and the London Marathon, and my heart rate jumped up to 220 beats a minute during the races, which was scary. I’ve had different diagnoses from stress with my work to potentially low blood sugar’, he explains.
Then, a year ago, he was finally given a diagnosis. After an event where his heart raced constantly at 220BPM, he decided he’d had enough and went back to his cardiologist and demanded answers.
‘My doctor told me to buy a Kardia monitor, which is an ECG device you attach to your phone so you can track a cardiac event when it happens. The day after I bought it, I had an episode and caught it with the monitor, sent it to my cardiologist, and he knew immediately what it w *** Lo
(c) Dukas -
DUK10163226_006
Herzerkrankung von den Doktoren übersehen: Dan Cipriani konnte dank seiner neuen Smartwatch selbst eine supraventrikuläre Tachykardie diagnostizieren
SONDERKONDITIONEN: Satzpreis!
WORDS BYLINE: Sarah Ingram
The symptoms were scary. Dan Cipriani’s heart rate would speed up and he would feel lightheaded and dizzy - sometimes while exercising and at others while he was at rest.
Dan first went to the doctor when he was 13 with sudden random onset palpitations, but he left the GP’s office without answers.
Dan went back another five times over the years and always left with doctors scratching their heads.
He was given a battery of tests; wearing a heart monitor for days on end or booking into hospital for echocardiograms and ECGs - but nothing was conclusive.
Meanwhile, the episodes kept happening. Dan’s heart rate would reach 220 BPM while sitting down; when it should have been between 60 and 100.
The 32-year-old banking director from London has always been fitness-mad.
He has run countless sub-three hour marathons, three ultra marathons including one 100-mile race and has competed in an Ironman.
He could not be healthier, but each time he would exercise, he would experience these troubling episodes.
‘They happened probably once a fortnight but then became more frequent over the last two years and would last longer, perhaps up to a minute,’ he says.
‘They also always happened during intense exercise. I did an Ironman triathlon and the London Marathon, and my heart rate jumped up to 220 beats a minute during the races, which was scary. I’ve had different diagnoses from stress with my work to potentially low blood sugar’, he explains.
Then, a year ago, he was finally given a diagnosis. After an event where his heart raced constantly at 220BPM, he decided he’d had enough and went back to his cardiologist and demanded answers.
‘My doctor told me to buy a Kardia monitor, which is an ECG device you attach to your phone so you can track a cardiac event when it happens. The day after I bought it, I had an episode and caught it with the monitor, sent it to my cardiologist, and he knew immediately what it w *** Lo
(c) Dukas -
DUK10163226_003
Herzerkrankung von den Doktoren übersehen: Dan Cipriani konnte dank seiner neuen Smartwatch selbst eine supraventrikuläre Tachykardie diagnostizieren
SONDERKONDITIONEN: Satzpreis!
WORDS BYLINE: Sarah Ingram
The symptoms were scary. Dan Cipriani’s heart rate would speed up and he would feel lightheaded and dizzy - sometimes while exercising and at others while he was at rest.
Dan first went to the doctor when he was 13 with sudden random onset palpitations, but he left the GP’s office without answers.
Dan went back another five times over the years and always left with doctors scratching their heads.
He was given a battery of tests; wearing a heart monitor for days on end or booking into hospital for echocardiograms and ECGs - but nothing was conclusive.
Meanwhile, the episodes kept happening. Dan’s heart rate would reach 220 BPM while sitting down; when it should have been between 60 and 100.
The 32-year-old banking director from London has always been fitness-mad.
He has run countless sub-three hour marathons, three ultra marathons including one 100-mile race and has competed in an Ironman.
He could not be healthier, but each time he would exercise, he would experience these troubling episodes.
‘They happened probably once a fortnight but then became more frequent over the last two years and would last longer, perhaps up to a minute,’ he says.
‘They also always happened during intense exercise. I did an Ironman triathlon and the London Marathon, and my heart rate jumped up to 220 beats a minute during the races, which was scary. I’ve had different diagnoses from stress with my work to potentially low blood sugar’, he explains.
Then, a year ago, he was finally given a diagnosis. After an event where his heart raced constantly at 220BPM, he decided he’d had enough and went back to his cardiologist and demanded answers.
‘My doctor told me to buy a Kardia monitor, which is an ECG device you attach to your phone so you can track a cardiac event when it happens. The day after I bought it, I had an episode and caught it with the monitor, sent it to my cardiologist, and he knew immediately what it w *** Lo
(c) Dukas -
DUK10163226_002
Herzerkrankung von den Doktoren übersehen: Dan Cipriani konnte dank seiner neuen Smartwatch selbst eine supraventrikuläre Tachykardie diagnostizieren
SONDERKONDITIONEN: Satzpreis!
WORDS BYLINE: Sarah Ingram
The symptoms were scary. Dan Cipriani’s heart rate would speed up and he would feel lightheaded and dizzy - sometimes while exercising and at others while he was at rest.
Dan first went to the doctor when he was 13 with sudden random onset palpitations, but he left the GP’s office without answers.
Dan went back another five times over the years and always left with doctors scratching their heads.
He was given a battery of tests; wearing a heart monitor for days on end or booking into hospital for echocardiograms and ECGs - but nothing was conclusive.
Meanwhile, the episodes kept happening. Dan’s heart rate would reach 220 BPM while sitting down; when it should have been between 60 and 100.
The 32-year-old banking director from London has always been fitness-mad.
He has run countless sub-three hour marathons, three ultra marathons including one 100-mile race and has competed in an Ironman.
He could not be healthier, but each time he would exercise, he would experience these troubling episodes.
‘They happened probably once a fortnight but then became more frequent over the last two years and would last longer, perhaps up to a minute,’ he says.
‘They also always happened during intense exercise. I did an Ironman triathlon and the London Marathon, and my heart rate jumped up to 220 beats a minute during the races, which was scary. I’ve had different diagnoses from stress with my work to potentially low blood sugar’, he explains.
Then, a year ago, he was finally given a diagnosis. After an event where his heart raced constantly at 220BPM, he decided he’d had enough and went back to his cardiologist and demanded answers.
‘My doctor told me to buy a Kardia monitor, which is an ECG device you attach to your phone so you can track a cardiac event when it happens. The day after I bought it, I had an episode and caught it with the monitor, sent it to my cardiologist, and he knew immediately what it w *** Lo
(c) Dukas -
DUK10163226_001
Herzerkrankung von den Doktoren übersehen: Dan Cipriani konnte dank seiner neuen Smartwatch selbst eine supraventrikuläre Tachykardie diagnostizieren
SONDERKONDITIONEN: Satzpreis!
WORDS BYLINE: Sarah Ingram
The symptoms were scary. Dan Cipriani’s heart rate would speed up and he would feel lightheaded and dizzy - sometimes while exercising and at others while he was at rest.
Dan first went to the doctor when he was 13 with sudden random onset palpitations, but he left the GP’s office without answers.
Dan went back another five times over the years and always left with doctors scratching their heads.
He was given a battery of tests; wearing a heart monitor for days on end or booking into hospital for echocardiograms and ECGs - but nothing was conclusive.
Meanwhile, the episodes kept happening. Dan’s heart rate would reach 220 BPM while sitting down; when it should have been between 60 and 100.
The 32-year-old banking director from London has always been fitness-mad.
He has run countless sub-three hour marathons, three ultra marathons including one 100-mile race and has competed in an Ironman.
He could not be healthier, but each time he would exercise, he would experience these troubling episodes.
‘They happened probably once a fortnight but then became more frequent over the last two years and would last longer, perhaps up to a minute,’ he says.
‘They also always happened during intense exercise. I did an Ironman triathlon and the London Marathon, and my heart rate jumped up to 220 beats a minute during the races, which was scary. I’ve had different diagnoses from stress with my work to potentially low blood sugar’, he explains.
Then, a year ago, he was finally given a diagnosis. After an event where his heart raced constantly at 220BPM, he decided he’d had enough and went back to his cardiologist and demanded answers.
‘My doctor told me to buy a Kardia monitor, which is an ECG device you attach to your phone so you can track a cardiac event when it happens. The day after I bought it, I had an episode and caught it with the monitor, sent it to my cardiologist, and he knew immediately what it w *** Lo
(c) Dukas -
DUK10163226_005
Herzerkrankung von den Doktoren übersehen: Dan Cipriani konnte dank seiner neuen Smartwatch selbst eine supraventrikuläre Tachykardie diagnostizieren
SONDERKONDITIONEN: Satzpreis!
WORDS BYLINE: Sarah Ingram
The symptoms were scary. Dan Cipriani’s heart rate would speed up and he would feel lightheaded and dizzy - sometimes while exercising and at others while he was at rest.
Dan first went to the doctor when he was 13 with sudden random onset palpitations, but he left the GP’s office without answers.
Dan went back another five times over the years and always left with doctors scratching their heads.
He was given a battery of tests; wearing a heart monitor for days on end or booking into hospital for echocardiograms and ECGs - but nothing was conclusive.
Meanwhile, the episodes kept happening. Dan’s heart rate would reach 220 BPM while sitting down; when it should have been between 60 and 100.
The 32-year-old banking director from London has always been fitness-mad.
He has run countless sub-three hour marathons, three ultra marathons including one 100-mile race and has competed in an Ironman.
He could not be healthier, but each time he would exercise, he would experience these troubling episodes.
‘They happened probably once a fortnight but then became more frequent over the last two years and would last longer, perhaps up to a minute,’ he says.
‘They also always happened during intense exercise. I did an Ironman triathlon and the London Marathon, and my heart rate jumped up to 220 beats a minute during the races, which was scary. I’ve had different diagnoses from stress with my work to potentially low blood sugar’, he explains.
Then, a year ago, he was finally given a diagnosis. After an event where his heart raced constantly at 220BPM, he decided he’d had enough and went back to his cardiologist and demanded answers.
‘My doctor told me to buy a Kardia monitor, which is an ECG device you attach to your phone so you can track a cardiac event when it happens. The day after I bought it, I had an episode and caught it with the monitor, sent it to my cardiologist, and he knew immediately what it w *** Lo
(c) Dukas -
DUK10163096_002
Emma hat 'nen Blindenhund: Emma Norman aus Biggleswade hat die ZSD Augenerkrankung und ist auf ihren Assistenzhund Archie angewiesen
SONDERKONDITIONEN: Satzpreis!
WORDS BYLINE: Deborah Cicurel
She was just a normal kid, running around with her friends and having fun dancing - until a devastating diagnosis.
When Emma Norman was six her parents noticed her squinting at the TV but they didn’t think too much of it.
However, Emma, now 33, would soon find out that she had Cone Rod Dystrophy and would eventually go blind.
Emma, a Pilates and meditation breathwork instructor from London, living in Biggleswade, Bedfordshire, believes the stereotypes around blindness made accepting her diagnosis even harder — and she wants to challenge outdated ideas around sight loss.
“Life before my diagnosis felt pretty normal,” she remembers.
“I was just like any other kid—running around with friends, dancing around to my favourite TV shows and records. I even skipped crawling and went straight to walking, and I was reading and talking from a very young age, so nobody noticed anything unusual.
“To me, everything seemed fine because that was just my normal. It wasn’t until my parents started picking up on little things—like me squinting at the TV or struggling to see animals at the zoo when they pointed them out—that they became curious.
“At first, they thought I was just being cheeky, pretending not to see things, but when I kept squinting at the TV, they decided to take me to the optician. They assumed I was probably just short-sighted and needed glasses.
“In my early years at school, I only needed to sit closer to the board, but beyond that, I didn’t notice anything different. I guess what I saw—how I saw—was just my normal.
“When I first started squinting, my parents thought I probably just needed glasses for short-sightedness, like the other kids in my class.
“The optician gave me my first pair of multi-coloured glasses in the meantime while they arranged for the doctors to refer me to Moorfields Eye Hospital, as they could tell something more was going on.
“After getting the gl *** Local Caption ***
(c) Dukas -
DUK10163096_013
Emma hat 'nen Blindenhund: Emma Norman aus Biggleswade hat die ZSD Augenerkrankung und ist auf ihren Assistenzhund Archie angewiesen
SONDERKONDITIONEN: Satzpreis!
WORDS BYLINE: Deborah Cicurel
She was just a normal kid, running around with her friends and having fun dancing - until a devastating diagnosis.
When Emma Norman was six her parents noticed her squinting at the TV but they didn’t think too much of it.
However, Emma, now 33, would soon find out that she had Cone Rod Dystrophy and would eventually go blind.
Emma, a Pilates and meditation breathwork instructor from London, living in Biggleswade, Bedfordshire, believes the stereotypes around blindness made accepting her diagnosis even harder — and she wants to challenge outdated ideas around sight loss.
“Life before my diagnosis felt pretty normal,” she remembers.
“I was just like any other kid—running around with friends, dancing around to my favourite TV shows and records. I even skipped crawling and went straight to walking, and I was reading and talking from a very young age, so nobody noticed anything unusual.
“To me, everything seemed fine because that was just my normal. It wasn’t until my parents started picking up on little things—like me squinting at the TV or struggling to see animals at the zoo when they pointed them out—that they became curious.
“At first, they thought I was just being cheeky, pretending not to see things, but when I kept squinting at the TV, they decided to take me to the optician. They assumed I was probably just short-sighted and needed glasses.
“In my early years at school, I only needed to sit closer to the board, but beyond that, I didn’t notice anything different. I guess what I saw—how I saw—was just my normal.
“When I first started squinting, my parents thought I probably just needed glasses for short-sightedness, like the other kids in my class.
“The optician gave me my first pair of multi-coloured glasses in the meantime while they arranged for the doctors to refer me to Moorfields Eye Hospital, as they could tell something more was going on.
“After getting the gl *** Local Caption ***
(c) Dukas -
DUK10163096_011
Emma hat 'nen Blindenhund: Emma Norman aus Biggleswade hat die ZSD Augenerkrankung und ist auf ihren Assistenzhund Archie angewiesen
SONDERKONDITIONEN: Satzpreis!
WORDS BYLINE: Deborah Cicurel
She was just a normal kid, running around with her friends and having fun dancing - until a devastating diagnosis.
When Emma Norman was six her parents noticed her squinting at the TV but they didn’t think too much of it.
However, Emma, now 33, would soon find out that she had Cone Rod Dystrophy and would eventually go blind.
Emma, a Pilates and meditation breathwork instructor from London, living in Biggleswade, Bedfordshire, believes the stereotypes around blindness made accepting her diagnosis even harder — and she wants to challenge outdated ideas around sight loss.
“Life before my diagnosis felt pretty normal,” she remembers.
“I was just like any other kid—running around with friends, dancing around to my favourite TV shows and records. I even skipped crawling and went straight to walking, and I was reading and talking from a very young age, so nobody noticed anything unusual.
“To me, everything seemed fine because that was just my normal. It wasn’t until my parents started picking up on little things—like me squinting at the TV or struggling to see animals at the zoo when they pointed them out—that they became curious.
“At first, they thought I was just being cheeky, pretending not to see things, but when I kept squinting at the TV, they decided to take me to the optician. They assumed I was probably just short-sighted and needed glasses.
“In my early years at school, I only needed to sit closer to the board, but beyond that, I didn’t notice anything different. I guess what I saw—how I saw—was just my normal.
“When I first started squinting, my parents thought I probably just needed glasses for short-sightedness, like the other kids in my class.
“The optician gave me my first pair of multi-coloured glasses in the meantime while they arranged for the doctors to refer me to Moorfields Eye Hospital, as they could tell something more was going on.
“After getting the gl *** Local Caption ***
(c) Dukas -
DUK10163096_003
Emma hat 'nen Blindenhund: Emma Norman aus Biggleswade hat die ZSD Augenerkrankung und ist auf ihren Assistenzhund Archie angewiesen
SONDERKONDITIONEN: Satzpreis!
WORDS BYLINE: Deborah Cicurel
She was just a normal kid, running around with her friends and having fun dancing - until a devastating diagnosis.
When Emma Norman was six her parents noticed her squinting at the TV but they didn’t think too much of it.
However, Emma, now 33, would soon find out that she had Cone Rod Dystrophy and would eventually go blind.
Emma, a Pilates and meditation breathwork instructor from London, living in Biggleswade, Bedfordshire, believes the stereotypes around blindness made accepting her diagnosis even harder — and she wants to challenge outdated ideas around sight loss.
“Life before my diagnosis felt pretty normal,” she remembers.
“I was just like any other kid—running around with friends, dancing around to my favourite TV shows and records. I even skipped crawling and went straight to walking, and I was reading and talking from a very young age, so nobody noticed anything unusual.
“To me, everything seemed fine because that was just my normal. It wasn’t until my parents started picking up on little things—like me squinting at the TV or struggling to see animals at the zoo when they pointed them out—that they became curious.
“At first, they thought I was just being cheeky, pretending not to see things, but when I kept squinting at the TV, they decided to take me to the optician. They assumed I was probably just short-sighted and needed glasses.
“In my early years at school, I only needed to sit closer to the board, but beyond that, I didn’t notice anything different. I guess what I saw—how I saw—was just my normal.
“When I first started squinting, my parents thought I probably just needed glasses for short-sightedness, like the other kids in my class.
“The optician gave me my first pair of multi-coloured glasses in the meantime while they arranged for the doctors to refer me to Moorfields Eye Hospital, as they could tell something more was going on.
“After getting the gl *** Local Caption ***
(c) Dukas -
DUK10163096_001
Emma hat 'nen Blindenhund: Emma Norman aus Biggleswade hat die ZSD Augenerkrankung und ist auf ihren Assistenzhund Archie angewiesen
SONDERKONDITIONEN: Satzpreis!
WORDS BYLINE: Deborah Cicurel
She was just a normal kid, running around with her friends and having fun dancing - until a devastating diagnosis.
When Emma Norman was six her parents noticed her squinting at the TV but they didn’t think too much of it.
However, Emma, now 33, would soon find out that she had Cone Rod Dystrophy and would eventually go blind.
Emma, a Pilates and meditation breathwork instructor from London, living in Biggleswade, Bedfordshire, believes the stereotypes around blindness made accepting her diagnosis even harder — and she wants to challenge outdated ideas around sight loss.
“Life before my diagnosis felt pretty normal,” she remembers.
“I was just like any other kid—running around with friends, dancing around to my favourite TV shows and records. I even skipped crawling and went straight to walking, and I was reading and talking from a very young age, so nobody noticed anything unusual.
“To me, everything seemed fine because that was just my normal. It wasn’t until my parents started picking up on little things—like me squinting at the TV or struggling to see animals at the zoo when they pointed them out—that they became curious.
“At first, they thought I was just being cheeky, pretending not to see things, but when I kept squinting at the TV, they decided to take me to the optician. They assumed I was probably just short-sighted and needed glasses.
“In my early years at school, I only needed to sit closer to the board, but beyond that, I didn’t notice anything different. I guess what I saw—how I saw—was just my normal.
“When I first started squinting, my parents thought I probably just needed glasses for short-sightedness, like the other kids in my class.
“The optician gave me my first pair of multi-coloured glasses in the meantime while they arranged for the doctors to refer me to Moorfields Eye Hospital, as they could tell something more was going on.
“After getting the gl *** Local Caption ***
(c) Dukas -
DUK10163096_010
Emma hat 'nen Blindenhund: Emma Norman aus Biggleswade hat die ZSD Augenerkrankung und ist auf ihren Assistenzhund Archie angewiesen
SONDERKONDITIONEN: Satzpreis!
WORDS BYLINE: Deborah Cicurel
She was just a normal kid, running around with her friends and having fun dancing - until a devastating diagnosis.
When Emma Norman was six her parents noticed her squinting at the TV but they didn’t think too much of it.
However, Emma, now 33, would soon find out that she had Cone Rod Dystrophy and would eventually go blind.
Emma, a Pilates and meditation breathwork instructor from London, living in Biggleswade, Bedfordshire, believes the stereotypes around blindness made accepting her diagnosis even harder — and she wants to challenge outdated ideas around sight loss.
“Life before my diagnosis felt pretty normal,” she remembers.
“I was just like any other kid—running around with friends, dancing around to my favourite TV shows and records. I even skipped crawling and went straight to walking, and I was reading and talking from a very young age, so nobody noticed anything unusual.
“To me, everything seemed fine because that was just my normal. It wasn’t until my parents started picking up on little things—like me squinting at the TV or struggling to see animals at the zoo when they pointed them out—that they became curious.
“At first, they thought I was just being cheeky, pretending not to see things, but when I kept squinting at the TV, they decided to take me to the optician. They assumed I was probably just short-sighted and needed glasses.
“In my early years at school, I only needed to sit closer to the board, but beyond that, I didn’t notice anything different. I guess what I saw—how I saw—was just my normal.
“When I first started squinting, my parents thought I probably just needed glasses for short-sightedness, like the other kids in my class.
“The optician gave me my first pair of multi-coloured glasses in the meantime while they arranged for the doctors to refer me to Moorfields Eye Hospital, as they could tell something more was going on.
“After getting the gl *** Local Caption ***
(c) Dukas -
DUK10163096_008
Emma hat 'nen Blindenhund: Emma Norman aus Biggleswade hat die ZSD Augenerkrankung und ist auf ihren Assistenzhund Archie angewiesen
SONDERKONDITIONEN: Satzpreis!
WORDS BYLINE: Deborah Cicurel
She was just a normal kid, running around with her friends and having fun dancing - until a devastating diagnosis.
When Emma Norman was six her parents noticed her squinting at the TV but they didn’t think too much of it.
However, Emma, now 33, would soon find out that she had Cone Rod Dystrophy and would eventually go blind.
Emma, a Pilates and meditation breathwork instructor from London, living in Biggleswade, Bedfordshire, believes the stereotypes around blindness made accepting her diagnosis even harder — and she wants to challenge outdated ideas around sight loss.
“Life before my diagnosis felt pretty normal,” she remembers.
“I was just like any other kid—running around with friends, dancing around to my favourite TV shows and records. I even skipped crawling and went straight to walking, and I was reading and talking from a very young age, so nobody noticed anything unusual.
“To me, everything seemed fine because that was just my normal. It wasn’t until my parents started picking up on little things—like me squinting at the TV or struggling to see animals at the zoo when they pointed them out—that they became curious.
“At first, they thought I was just being cheeky, pretending not to see things, but when I kept squinting at the TV, they decided to take me to the optician. They assumed I was probably just short-sighted and needed glasses.
“In my early years at school, I only needed to sit closer to the board, but beyond that, I didn’t notice anything different. I guess what I saw—how I saw—was just my normal.
“When I first started squinting, my parents thought I probably just needed glasses for short-sightedness, like the other kids in my class.
“The optician gave me my first pair of multi-coloured glasses in the meantime while they arranged for the doctors to refer me to Moorfields Eye Hospital, as they could tell something more was going on.
“After getting the gl *** Local Caption ***
(c) Dukas -
DUK10163096_007
Emma hat 'nen Blindenhund: Emma Norman aus Biggleswade hat die ZSD Augenerkrankung und ist auf ihren Assistenzhund Archie angewiesen
SONDERKONDITIONEN: Satzpreis!
WORDS BYLINE: Deborah Cicurel
She was just a normal kid, running around with her friends and having fun dancing - until a devastating diagnosis.
When Emma Norman was six her parents noticed her squinting at the TV but they didn’t think too much of it.
However, Emma, now 33, would soon find out that she had Cone Rod Dystrophy and would eventually go blind.
Emma, a Pilates and meditation breathwork instructor from London, living in Biggleswade, Bedfordshire, believes the stereotypes around blindness made accepting her diagnosis even harder — and she wants to challenge outdated ideas around sight loss.
“Life before my diagnosis felt pretty normal,” she remembers.
“I was just like any other kid—running around with friends, dancing around to my favourite TV shows and records. I even skipped crawling and went straight to walking, and I was reading and talking from a very young age, so nobody noticed anything unusual.
“To me, everything seemed fine because that was just my normal. It wasn’t until my parents started picking up on little things—like me squinting at the TV or struggling to see animals at the zoo when they pointed them out—that they became curious.
“At first, they thought I was just being cheeky, pretending not to see things, but when I kept squinting at the TV, they decided to take me to the optician. They assumed I was probably just short-sighted and needed glasses.
“In my early years at school, I only needed to sit closer to the board, but beyond that, I didn’t notice anything different. I guess what I saw—how I saw—was just my normal.
“When I first started squinting, my parents thought I probably just needed glasses for short-sightedness, like the other kids in my class.
“The optician gave me my first pair of multi-coloured glasses in the meantime while they arranged for the doctors to refer me to Moorfields Eye Hospital, as they could tell something more was going on.
“After getting the gl *** Local Caption ***
(c) Dukas -
DUK10163096_006
Emma hat 'nen Blindenhund: Emma Norman aus Biggleswade hat die ZSD Augenerkrankung und ist auf ihren Assistenzhund Archie angewiesen
SONDERKONDITIONEN: Satzpreis!
WORDS BYLINE: Deborah Cicurel
She was just a normal kid, running around with her friends and having fun dancing - until a devastating diagnosis.
When Emma Norman was six her parents noticed her squinting at the TV but they didn’t think too much of it.
However, Emma, now 33, would soon find out that she had Cone Rod Dystrophy and would eventually go blind.
Emma, a Pilates and meditation breathwork instructor from London, living in Biggleswade, Bedfordshire, believes the stereotypes around blindness made accepting her diagnosis even harder — and she wants to challenge outdated ideas around sight loss.
“Life before my diagnosis felt pretty normal,” she remembers.
“I was just like any other kid—running around with friends, dancing around to my favourite TV shows and records. I even skipped crawling and went straight to walking, and I was reading and talking from a very young age, so nobody noticed anything unusual.
“To me, everything seemed fine because that was just my normal. It wasn’t until my parents started picking up on little things—like me squinting at the TV or struggling to see animals at the zoo when they pointed them out—that they became curious.
“At first, they thought I was just being cheeky, pretending not to see things, but when I kept squinting at the TV, they decided to take me to the optician. They assumed I was probably just short-sighted and needed glasses.
“In my early years at school, I only needed to sit closer to the board, but beyond that, I didn’t notice anything different. I guess what I saw—how I saw—was just my normal.
“When I first started squinting, my parents thought I probably just needed glasses for short-sightedness, like the other kids in my class.
“The optician gave me my first pair of multi-coloured glasses in the meantime while they arranged for the doctors to refer me to Moorfields Eye Hospital, as they could tell something more was going on.
“After getting the gl *** Local Caption ***
(c) Dukas -
DUK10163096_009
Emma hat 'nen Blindenhund: Emma Norman aus Biggleswade hat die ZSD Augenerkrankung und ist auf ihren Assistenzhund Archie angewiesen
SONDERKONDITIONEN: Satzpreis!
WORDS BYLINE: Deborah Cicurel
She was just a normal kid, running around with her friends and having fun dancing - until a devastating diagnosis.
When Emma Norman was six her parents noticed her squinting at the TV but they didn’t think too much of it.
However, Emma, now 33, would soon find out that she had Cone Rod Dystrophy and would eventually go blind.
Emma, a Pilates and meditation breathwork instructor from London, living in Biggleswade, Bedfordshire, believes the stereotypes around blindness made accepting her diagnosis even harder — and she wants to challenge outdated ideas around sight loss.
“Life before my diagnosis felt pretty normal,” she remembers.
“I was just like any other kid—running around with friends, dancing around to my favourite TV shows and records. I even skipped crawling and went straight to walking, and I was reading and talking from a very young age, so nobody noticed anything unusual.
“To me, everything seemed fine because that was just my normal. It wasn’t until my parents started picking up on little things—like me squinting at the TV or struggling to see animals at the zoo when they pointed them out—that they became curious.
“At first, they thought I was just being cheeky, pretending not to see things, but when I kept squinting at the TV, they decided to take me to the optician. They assumed I was probably just short-sighted and needed glasses.
“In my early years at school, I only needed to sit closer to the board, but beyond that, I didn’t notice anything different. I guess what I saw—how I saw—was just my normal.
“When I first started squinting, my parents thought I probably just needed glasses for short-sightedness, like the other kids in my class.
“The optician gave me my first pair of multi-coloured glasses in the meantime while they arranged for the doctors to refer me to Moorfields Eye Hospital, as they could tell something more was going on.
“After getting the gl *** Local Caption ***
(c) Dukas -
DUK10163096_004
Emma hat 'nen Blindenhund: Emma Norman aus Biggleswade hat die ZSD Augenerkrankung und ist auf ihren Assistenzhund Archie angewiesen
SONDERKONDITIONEN: Satzpreis!
WORDS BYLINE: Deborah Cicurel
She was just a normal kid, running around with her friends and having fun dancing - until a devastating diagnosis.
When Emma Norman was six her parents noticed her squinting at the TV but they didn’t think too much of it.
However, Emma, now 33, would soon find out that she had Cone Rod Dystrophy and would eventually go blind.
Emma, a Pilates and meditation breathwork instructor from London, living in Biggleswade, Bedfordshire, believes the stereotypes around blindness made accepting her diagnosis even harder — and she wants to challenge outdated ideas around sight loss.
“Life before my diagnosis felt pretty normal,” she remembers.
“I was just like any other kid—running around with friends, dancing around to my favourite TV shows and records. I even skipped crawling and went straight to walking, and I was reading and talking from a very young age, so nobody noticed anything unusual.
“To me, everything seemed fine because that was just my normal. It wasn’t until my parents started picking up on little things—like me squinting at the TV or struggling to see animals at the zoo when they pointed them out—that they became curious.
“At first, they thought I was just being cheeky, pretending not to see things, but when I kept squinting at the TV, they decided to take me to the optician. They assumed I was probably just short-sighted and needed glasses.
“In my early years at school, I only needed to sit closer to the board, but beyond that, I didn’t notice anything different. I guess what I saw—how I saw—was just my normal.
“When I first started squinting, my parents thought I probably just needed glasses for short-sightedness, like the other kids in my class.
“The optician gave me my first pair of multi-coloured glasses in the meantime while they arranged for the doctors to refer me to Moorfields Eye Hospital, as they could tell something more was going on.
“After getting the gl *** Local Caption ***
(c) Dukas -
DUK10163096_012
Emma hat 'nen Blindenhund: Emma Norman aus Biggleswade hat die ZSD Augenerkrankung und ist auf ihren Assistenzhund Archie angewiesen
SONDERKONDITIONEN: Satzpreis!
WORDS BYLINE: Deborah Cicurel
She was just a normal kid, running around with her friends and having fun dancing - until a devastating diagnosis.
When Emma Norman was six her parents noticed her squinting at the TV but they didn’t think too much of it.
However, Emma, now 33, would soon find out that she had Cone Rod Dystrophy and would eventually go blind.
Emma, a Pilates and meditation breathwork instructor from London, living in Biggleswade, Bedfordshire, believes the stereotypes around blindness made accepting her diagnosis even harder — and she wants to challenge outdated ideas around sight loss.
“Life before my diagnosis felt pretty normal,” she remembers.
“I was just like any other kid—running around with friends, dancing around to my favourite TV shows and records. I even skipped crawling and went straight to walking, and I was reading and talking from a very young age, so nobody noticed anything unusual.
“To me, everything seemed fine because that was just my normal. It wasn’t until my parents started picking up on little things—like me squinting at the TV or struggling to see animals at the zoo when they pointed them out—that they became curious.
“At first, they thought I was just being cheeky, pretending not to see things, but when I kept squinting at the TV, they decided to take me to the optician. They assumed I was probably just short-sighted and needed glasses.
“In my early years at school, I only needed to sit closer to the board, but beyond that, I didn’t notice anything different. I guess what I saw—how I saw—was just my normal.
“When I first started squinting, my parents thought I probably just needed glasses for short-sightedness, like the other kids in my class.
“The optician gave me my first pair of multi-coloured glasses in the meantime while they arranged for the doctors to refer me to Moorfields Eye Hospital, as they could tell something more was going on.
“After getting the gl *** Local Caption ***
(c) Dukas -
DUK10163096_005
Emma hat 'nen Blindenhund: Emma Norman aus Biggleswade hat die ZSD Augenerkrankung und ist auf ihren Assistenzhund Archie angewiesen
SONDERKONDITIONEN: Satzpreis!
WORDS BYLINE: Deborah Cicurel
She was just a normal kid, running around with her friends and having fun dancing - until a devastating diagnosis.
When Emma Norman was six her parents noticed her squinting at the TV but they didn’t think too much of it.
However, Emma, now 33, would soon find out that she had Cone Rod Dystrophy and would eventually go blind.
Emma, a Pilates and meditation breathwork instructor from London, living in Biggleswade, Bedfordshire, believes the stereotypes around blindness made accepting her diagnosis even harder — and she wants to challenge outdated ideas around sight loss.
“Life before my diagnosis felt pretty normal,” she remembers.
“I was just like any other kid—running around with friends, dancing around to my favourite TV shows and records. I even skipped crawling and went straight to walking, and I was reading and talking from a very young age, so nobody noticed anything unusual.
“To me, everything seemed fine because that was just my normal. It wasn’t until my parents started picking up on little things—like me squinting at the TV or struggling to see animals at the zoo when they pointed them out—that they became curious.
“At first, they thought I was just being cheeky, pretending not to see things, but when I kept squinting at the TV, they decided to take me to the optician. They assumed I was probably just short-sighted and needed glasses.
“In my early years at school, I only needed to sit closer to the board, but beyond that, I didn’t notice anything different. I guess what I saw—how I saw—was just my normal.
“When I first started squinting, my parents thought I probably just needed glasses for short-sightedness, like the other kids in my class.
“The optician gave me my first pair of multi-coloured glasses in the meantime while they arranged for the doctors to refer me to Moorfields Eye Hospital, as they could tell something more was going on.
“After getting the gl *** Local Caption ***
(c) Dukas -
DUK10163088_012
Hielt ihre Beschwerden für Covid: Bei der 27jährigen Evgenia aus London wurde eine aggressive Krebsart diagnostiziert
SONDERKONDITIONEN: Satzpreis!
WORDS BYLINE: Deborah Cicurel
For months, she brushed off the symptoms. The nagging pain in her shoulder blade, an irritating cough, and relentless fatigue all seemed like nothing serious.
But when Evgenia’s pain worsened, her energy drained, and a mysterious rash appeared, she knew something wasn’t right.
“I didn't really think that anything was going wrong until I really started feeling the pain in the shoulder blade getting more and more intense,” the 27-year-old says.
“I started coughing at some point as well, and this is when I thought maybe I’d got Covid. I didn't really pay much attention to it.
“Then it started getting really bad and I wouldn't be able to speak. I would cough all the time, and it really interfered with my day-to-day stuff.”
In March 2023 she decided to seek help. At first, doctors were unconcerned. An MRI of her neck revealed nothing alarming - except, by sheer luck, a small glimpse of a lump lower in her chest.
Evgenia, 25 at the time, was referred to a lung specialist but the appointment was delayed. Precious weeks ticked by before she could get further tests.
By the time she underwent a biopsy in July, her condition had deteriorated significantly.
The persistent cough made speaking difficult, everyday tasks left her exhausted, and what had started as a vague discomfort had become an overwhelming burden.
Then came the words no one ever expects to hear: Stage 4 lymphoma.
“I had a feeling before that I might have cancer,” Evgenia, from London, remembers. “I think actually knowing the diagnosis is much better than not knowing it.
“Of course I was upset and I couldn't believe the diagnosis for a bit, and I was like, ‘This cannot be happening to me. Why me?’
“But in a way it was a relief: when you don't know your diagnosis yet, you feel super frustrated because you know that you are getting worse and worse every day.
“And then when I finally found out the diagnosis, things started h *** Local Captio
(c) Dukas -
DUK10163088_011
Hielt ihre Beschwerden für Covid: Bei der 27jährigen Evgenia aus London wurde eine aggressive Krebsart diagnostiziert
SONDERKONDITIONEN: Satzpreis!
WORDS BYLINE: Deborah Cicurel
For months, she brushed off the symptoms. The nagging pain in her shoulder blade, an irritating cough, and relentless fatigue all seemed like nothing serious.
But when Evgenia’s pain worsened, her energy drained, and a mysterious rash appeared, she knew something wasn’t right.
“I didn't really think that anything was going wrong until I really started feeling the pain in the shoulder blade getting more and more intense,” the 27-year-old says.
“I started coughing at some point as well, and this is when I thought maybe I’d got Covid. I didn't really pay much attention to it.
“Then it started getting really bad and I wouldn't be able to speak. I would cough all the time, and it really interfered with my day-to-day stuff.”
In March 2023 she decided to seek help. At first, doctors were unconcerned. An MRI of her neck revealed nothing alarming - except, by sheer luck, a small glimpse of a lump lower in her chest.
Evgenia, 25 at the time, was referred to a lung specialist but the appointment was delayed. Precious weeks ticked by before she could get further tests.
By the time she underwent a biopsy in July, her condition had deteriorated significantly.
The persistent cough made speaking difficult, everyday tasks left her exhausted, and what had started as a vague discomfort had become an overwhelming burden.
Then came the words no one ever expects to hear: Stage 4 lymphoma.
“I had a feeling before that I might have cancer,” Evgenia, from London, remembers. “I think actually knowing the diagnosis is much better than not knowing it.
“Of course I was upset and I couldn't believe the diagnosis for a bit, and I was like, ‘This cannot be happening to me. Why me?’
“But in a way it was a relief: when you don't know your diagnosis yet, you feel super frustrated because you know that you are getting worse and worse every day.
“And then when I finally found out the diagnosis, things started h *** Local Captio
(c) Dukas -
DUK10163088_008
Hielt ihre Beschwerden für Covid: Bei der 27jährigen Evgenia aus London wurde eine aggressive Krebsart diagnostiziert
SONDERKONDITIONEN: Satzpreis!
WORDS BYLINE: Deborah Cicurel
For months, she brushed off the symptoms. The nagging pain in her shoulder blade, an irritating cough, and relentless fatigue all seemed like nothing serious.
But when Evgenia’s pain worsened, her energy drained, and a mysterious rash appeared, she knew something wasn’t right.
“I didn't really think that anything was going wrong until I really started feeling the pain in the shoulder blade getting more and more intense,” the 27-year-old says.
“I started coughing at some point as well, and this is when I thought maybe I’d got Covid. I didn't really pay much attention to it.
“Then it started getting really bad and I wouldn't be able to speak. I would cough all the time, and it really interfered with my day-to-day stuff.”
In March 2023 she decided to seek help. At first, doctors were unconcerned. An MRI of her neck revealed nothing alarming - except, by sheer luck, a small glimpse of a lump lower in her chest.
Evgenia, 25 at the time, was referred to a lung specialist but the appointment was delayed. Precious weeks ticked by before she could get further tests.
By the time she underwent a biopsy in July, her condition had deteriorated significantly.
The persistent cough made speaking difficult, everyday tasks left her exhausted, and what had started as a vague discomfort had become an overwhelming burden.
Then came the words no one ever expects to hear: Stage 4 lymphoma.
“I had a feeling before that I might have cancer,” Evgenia, from London, remembers. “I think actually knowing the diagnosis is much better than not knowing it.
“Of course I was upset and I couldn't believe the diagnosis for a bit, and I was like, ‘This cannot be happening to me. Why me?’
“But in a way it was a relief: when you don't know your diagnosis yet, you feel super frustrated because you know that you are getting worse and worse every day.
“And then when I finally found out the diagnosis, things started h *** Local Captio
(c) Dukas -
DUK10163088_009
Hielt ihre Beschwerden für Covid: Bei der 27jährigen Evgenia aus London wurde eine aggressive Krebsart diagnostiziert
SONDERKONDITIONEN: Satzpreis!
WORDS BYLINE: Deborah Cicurel
For months, she brushed off the symptoms. The nagging pain in her shoulder blade, an irritating cough, and relentless fatigue all seemed like nothing serious.
But when Evgenia’s pain worsened, her energy drained, and a mysterious rash appeared, she knew something wasn’t right.
“I didn't really think that anything was going wrong until I really started feeling the pain in the shoulder blade getting more and more intense,” the 27-year-old says.
“I started coughing at some point as well, and this is when I thought maybe I’d got Covid. I didn't really pay much attention to it.
“Then it started getting really bad and I wouldn't be able to speak. I would cough all the time, and it really interfered with my day-to-day stuff.”
In March 2023 she decided to seek help. At first, doctors were unconcerned. An MRI of her neck revealed nothing alarming - except, by sheer luck, a small glimpse of a lump lower in her chest.
Evgenia, 25 at the time, was referred to a lung specialist but the appointment was delayed. Precious weeks ticked by before she could get further tests.
By the time she underwent a biopsy in July, her condition had deteriorated significantly.
The persistent cough made speaking difficult, everyday tasks left her exhausted, and what had started as a vague discomfort had become an overwhelming burden.
Then came the words no one ever expects to hear: Stage 4 lymphoma.
“I had a feeling before that I might have cancer,” Evgenia, from London, remembers. “I think actually knowing the diagnosis is much better than not knowing it.
“Of course I was upset and I couldn't believe the diagnosis for a bit, and I was like, ‘This cannot be happening to me. Why me?’
“But in a way it was a relief: when you don't know your diagnosis yet, you feel super frustrated because you know that you are getting worse and worse every day.
“And then when I finally found out the diagnosis, things started h *** Local Captio
(c) Dukas -
DUK10163088_001
Hielt ihre Beschwerden für Covid: Bei der 27jährigen Evgenia aus London wurde eine aggressive Krebsart diagnostiziert
SONDERKONDITIONEN: Satzpreis!
WORDS BYLINE: Deborah Cicurel
For months, she brushed off the symptoms. The nagging pain in her shoulder blade, an irritating cough, and relentless fatigue all seemed like nothing serious.
But when Evgenia’s pain worsened, her energy drained, and a mysterious rash appeared, she knew something wasn’t right.
“I didn't really think that anything was going wrong until I really started feeling the pain in the shoulder blade getting more and more intense,” the 27-year-old says.
“I started coughing at some point as well, and this is when I thought maybe I’d got Covid. I didn't really pay much attention to it.
“Then it started getting really bad and I wouldn't be able to speak. I would cough all the time, and it really interfered with my day-to-day stuff.”
In March 2023 she decided to seek help. At first, doctors were unconcerned. An MRI of her neck revealed nothing alarming - except, by sheer luck, a small glimpse of a lump lower in her chest.
Evgenia, 25 at the time, was referred to a lung specialist but the appointment was delayed. Precious weeks ticked by before she could get further tests.
By the time she underwent a biopsy in July, her condition had deteriorated significantly.
The persistent cough made speaking difficult, everyday tasks left her exhausted, and what had started as a vague discomfort had become an overwhelming burden.
Then came the words no one ever expects to hear: Stage 4 lymphoma.
“I had a feeling before that I might have cancer,” Evgenia, from London, remembers. “I think actually knowing the diagnosis is much better than not knowing it.
“Of course I was upset and I couldn't believe the diagnosis for a bit, and I was like, ‘This cannot be happening to me. Why me?’
“But in a way it was a relief: when you don't know your diagnosis yet, you feel super frustrated because you know that you are getting worse and worse every day.
“And then when I finally found out the diagnosis, things started h *** Local Captio
(c) Dukas -
DUK10163088_004
Hielt ihre Beschwerden für Covid: Bei der 27jährigen Evgenia aus London wurde eine aggressive Krebsart diagnostiziert
SONDERKONDITIONEN: Satzpreis!
WORDS BYLINE: Deborah Cicurel
For months, she brushed off the symptoms. The nagging pain in her shoulder blade, an irritating cough, and relentless fatigue all seemed like nothing serious.
But when Evgenia’s pain worsened, her energy drained, and a mysterious rash appeared, she knew something wasn’t right.
“I didn't really think that anything was going wrong until I really started feeling the pain in the shoulder blade getting more and more intense,” the 27-year-old says.
“I started coughing at some point as well, and this is when I thought maybe I’d got Covid. I didn't really pay much attention to it.
“Then it started getting really bad and I wouldn't be able to speak. I would cough all the time, and it really interfered with my day-to-day stuff.”
In March 2023 she decided to seek help. At first, doctors were unconcerned. An MRI of her neck revealed nothing alarming - except, by sheer luck, a small glimpse of a lump lower in her chest.
Evgenia, 25 at the time, was referred to a lung specialist but the appointment was delayed. Precious weeks ticked by before she could get further tests.
By the time she underwent a biopsy in July, her condition had deteriorated significantly.
The persistent cough made speaking difficult, everyday tasks left her exhausted, and what had started as a vague discomfort had become an overwhelming burden.
Then came the words no one ever expects to hear: Stage 4 lymphoma.
“I had a feeling before that I might have cancer,” Evgenia, from London, remembers. “I think actually knowing the diagnosis is much better than not knowing it.
“Of course I was upset and I couldn't believe the diagnosis for a bit, and I was like, ‘This cannot be happening to me. Why me?’
“But in a way it was a relief: when you don't know your diagnosis yet, you feel super frustrated because you know that you are getting worse and worse every day.
“And then when I finally found out the diagnosis, things started h *** Local Captio
(c) Dukas -
DUK10163088_007
Hielt ihre Beschwerden für Covid: Bei der 27jährigen Evgenia aus London wurde eine aggressive Krebsart diagnostiziert
SONDERKONDITIONEN: Satzpreis!
WORDS BYLINE: Deborah Cicurel
For months, she brushed off the symptoms. The nagging pain in her shoulder blade, an irritating cough, and relentless fatigue all seemed like nothing serious.
But when Evgenia’s pain worsened, her energy drained, and a mysterious rash appeared, she knew something wasn’t right.
“I didn't really think that anything was going wrong until I really started feeling the pain in the shoulder blade getting more and more intense,” the 27-year-old says.
“I started coughing at some point as well, and this is when I thought maybe I’d got Covid. I didn't really pay much attention to it.
“Then it started getting really bad and I wouldn't be able to speak. I would cough all the time, and it really interfered with my day-to-day stuff.”
In March 2023 she decided to seek help. At first, doctors were unconcerned. An MRI of her neck revealed nothing alarming - except, by sheer luck, a small glimpse of a lump lower in her chest.
Evgenia, 25 at the time, was referred to a lung specialist but the appointment was delayed. Precious weeks ticked by before she could get further tests.
By the time she underwent a biopsy in July, her condition had deteriorated significantly.
The persistent cough made speaking difficult, everyday tasks left her exhausted, and what had started as a vague discomfort had become an overwhelming burden.
Then came the words no one ever expects to hear: Stage 4 lymphoma.
“I had a feeling before that I might have cancer,” Evgenia, from London, remembers. “I think actually knowing the diagnosis is much better than not knowing it.
“Of course I was upset and I couldn't believe the diagnosis for a bit, and I was like, ‘This cannot be happening to me. Why me?’
“But in a way it was a relief: when you don't know your diagnosis yet, you feel super frustrated because you know that you are getting worse and worse every day.
“And then when I finally found out the diagnosis, things started h *** Local Captio
(c) Dukas -
DUK10163088_006
Hielt ihre Beschwerden für Covid: Bei der 27jährigen Evgenia aus London wurde eine aggressive Krebsart diagnostiziert
SONDERKONDITIONEN: Satzpreis!
WORDS BYLINE: Deborah Cicurel
For months, she brushed off the symptoms. The nagging pain in her shoulder blade, an irritating cough, and relentless fatigue all seemed like nothing serious.
But when Evgenia’s pain worsened, her energy drained, and a mysterious rash appeared, she knew something wasn’t right.
“I didn't really think that anything was going wrong until I really started feeling the pain in the shoulder blade getting more and more intense,” the 27-year-old says.
“I started coughing at some point as well, and this is when I thought maybe I’d got Covid. I didn't really pay much attention to it.
“Then it started getting really bad and I wouldn't be able to speak. I would cough all the time, and it really interfered with my day-to-day stuff.”
In March 2023 she decided to seek help. At first, doctors were unconcerned. An MRI of her neck revealed nothing alarming - except, by sheer luck, a small glimpse of a lump lower in her chest.
Evgenia, 25 at the time, was referred to a lung specialist but the appointment was delayed. Precious weeks ticked by before she could get further tests.
By the time she underwent a biopsy in July, her condition had deteriorated significantly.
The persistent cough made speaking difficult, everyday tasks left her exhausted, and what had started as a vague discomfort had become an overwhelming burden.
Then came the words no one ever expects to hear: Stage 4 lymphoma.
“I had a feeling before that I might have cancer,” Evgenia, from London, remembers. “I think actually knowing the diagnosis is much better than not knowing it.
“Of course I was upset and I couldn't believe the diagnosis for a bit, and I was like, ‘This cannot be happening to me. Why me?’
“But in a way it was a relief: when you don't know your diagnosis yet, you feel super frustrated because you know that you are getting worse and worse every day.
“And then when I finally found out the diagnosis, things started h *** Local Captio
(c) Dukas -
DUK10163088_005
Hielt ihre Beschwerden für Covid: Bei der 27jährigen Evgenia aus London wurde eine aggressive Krebsart diagnostiziert
SONDERKONDITIONEN: Satzpreis!
WORDS BYLINE: Deborah Cicurel
For months, she brushed off the symptoms. The nagging pain in her shoulder blade, an irritating cough, and relentless fatigue all seemed like nothing serious.
But when Evgenia’s pain worsened, her energy drained, and a mysterious rash appeared, she knew something wasn’t right.
“I didn't really think that anything was going wrong until I really started feeling the pain in the shoulder blade getting more and more intense,” the 27-year-old says.
“I started coughing at some point as well, and this is when I thought maybe I’d got Covid. I didn't really pay much attention to it.
“Then it started getting really bad and I wouldn't be able to speak. I would cough all the time, and it really interfered with my day-to-day stuff.”
In March 2023 she decided to seek help. At first, doctors were unconcerned. An MRI of her neck revealed nothing alarming - except, by sheer luck, a small glimpse of a lump lower in her chest.
Evgenia, 25 at the time, was referred to a lung specialist but the appointment was delayed. Precious weeks ticked by before she could get further tests.
By the time she underwent a biopsy in July, her condition had deteriorated significantly.
The persistent cough made speaking difficult, everyday tasks left her exhausted, and what had started as a vague discomfort had become an overwhelming burden.
Then came the words no one ever expects to hear: Stage 4 lymphoma.
“I had a feeling before that I might have cancer,” Evgenia, from London, remembers. “I think actually knowing the diagnosis is much better than not knowing it.
“Of course I was upset and I couldn't believe the diagnosis for a bit, and I was like, ‘This cannot be happening to me. Why me?’
“But in a way it was a relief: when you don't know your diagnosis yet, you feel super frustrated because you know that you are getting worse and worse every day.
“And then when I finally found out the diagnosis, things started h *** Local Captio
(c) Dukas -
DUK10163088_014
Hielt ihre Beschwerden für Covid: Bei der 27jährigen Evgenia aus London wurde eine aggressive Krebsart diagnostiziert
SONDERKONDITIONEN: Satzpreis!
WORDS BYLINE: Deborah Cicurel
For months, she brushed off the symptoms. The nagging pain in her shoulder blade, an irritating cough, and relentless fatigue all seemed like nothing serious.
But when Evgenia’s pain worsened, her energy drained, and a mysterious rash appeared, she knew something wasn’t right.
“I didn't really think that anything was going wrong until I really started feeling the pain in the shoulder blade getting more and more intense,” the 27-year-old says.
“I started coughing at some point as well, and this is when I thought maybe I’d got Covid. I didn't really pay much attention to it.
“Then it started getting really bad and I wouldn't be able to speak. I would cough all the time, and it really interfered with my day-to-day stuff.”
In March 2023 she decided to seek help. At first, doctors were unconcerned. An MRI of her neck revealed nothing alarming - except, by sheer luck, a small glimpse of a lump lower in her chest.
Evgenia, 25 at the time, was referred to a lung specialist but the appointment was delayed. Precious weeks ticked by before she could get further tests.
By the time she underwent a biopsy in July, her condition had deteriorated significantly.
The persistent cough made speaking difficult, everyday tasks left her exhausted, and what had started as a vague discomfort had become an overwhelming burden.
Then came the words no one ever expects to hear: Stage 4 lymphoma.
“I had a feeling before that I might have cancer,” Evgenia, from London, remembers. “I think actually knowing the diagnosis is much better than not knowing it.
“Of course I was upset and I couldn't believe the diagnosis for a bit, and I was like, ‘This cannot be happening to me. Why me?’
“But in a way it was a relief: when you don't know your diagnosis yet, you feel super frustrated because you know that you are getting worse and worse every day.
“And then when I finally found out the diagnosis, things started h *** Local Captio
(c) Dukas -
DUK10163088_013
Hielt ihre Beschwerden für Covid: Bei der 27jährigen Evgenia aus London wurde eine aggressive Krebsart diagnostiziert
SONDERKONDITIONEN: Satzpreis!
WORDS BYLINE: Deborah Cicurel
For months, she brushed off the symptoms. The nagging pain in her shoulder blade, an irritating cough, and relentless fatigue all seemed like nothing serious.
But when Evgenia’s pain worsened, her energy drained, and a mysterious rash appeared, she knew something wasn’t right.
“I didn't really think that anything was going wrong until I really started feeling the pain in the shoulder blade getting more and more intense,” the 27-year-old says.
“I started coughing at some point as well, and this is when I thought maybe I’d got Covid. I didn't really pay much attention to it.
“Then it started getting really bad and I wouldn't be able to speak. I would cough all the time, and it really interfered with my day-to-day stuff.”
In March 2023 she decided to seek help. At first, doctors were unconcerned. An MRI of her neck revealed nothing alarming - except, by sheer luck, a small glimpse of a lump lower in her chest.
Evgenia, 25 at the time, was referred to a lung specialist but the appointment was delayed. Precious weeks ticked by before she could get further tests.
By the time she underwent a biopsy in July, her condition had deteriorated significantly.
The persistent cough made speaking difficult, everyday tasks left her exhausted, and what had started as a vague discomfort had become an overwhelming burden.
Then came the words no one ever expects to hear: Stage 4 lymphoma.
“I had a feeling before that I might have cancer,” Evgenia, from London, remembers. “I think actually knowing the diagnosis is much better than not knowing it.
“Of course I was upset and I couldn't believe the diagnosis for a bit, and I was like, ‘This cannot be happening to me. Why me?’
“But in a way it was a relief: when you don't know your diagnosis yet, you feel super frustrated because you know that you are getting worse and worse every day.
“And then when I finally found out the diagnosis, things started h *** Local Captio
(c) Dukas -
DUK10163088_003
Hielt ihre Beschwerden für Covid: Bei der 27jährigen Evgenia aus London wurde eine aggressive Krebsart diagnostiziert
SONDERKONDITIONEN: Satzpreis!
WORDS BYLINE: Deborah Cicurel
For months, she brushed off the symptoms. The nagging pain in her shoulder blade, an irritating cough, and relentless fatigue all seemed like nothing serious.
But when Evgenia’s pain worsened, her energy drained, and a mysterious rash appeared, she knew something wasn’t right.
“I didn't really think that anything was going wrong until I really started feeling the pain in the shoulder blade getting more and more intense,” the 27-year-old says.
“I started coughing at some point as well, and this is when I thought maybe I’d got Covid. I didn't really pay much attention to it.
“Then it started getting really bad and I wouldn't be able to speak. I would cough all the time, and it really interfered with my day-to-day stuff.”
In March 2023 she decided to seek help. At first, doctors were unconcerned. An MRI of her neck revealed nothing alarming - except, by sheer luck, a small glimpse of a lump lower in her chest.
Evgenia, 25 at the time, was referred to a lung specialist but the appointment was delayed. Precious weeks ticked by before she could get further tests.
By the time she underwent a biopsy in July, her condition had deteriorated significantly.
The persistent cough made speaking difficult, everyday tasks left her exhausted, and what had started as a vague discomfort had become an overwhelming burden.
Then came the words no one ever expects to hear: Stage 4 lymphoma.
“I had a feeling before that I might have cancer,” Evgenia, from London, remembers. “I think actually knowing the diagnosis is much better than not knowing it.
“Of course I was upset and I couldn't believe the diagnosis for a bit, and I was like, ‘This cannot be happening to me. Why me?’
“But in a way it was a relief: when you don't know your diagnosis yet, you feel super frustrated because you know that you are getting worse and worse every day.
“And then when I finally found out the diagnosis, things started h *** Local Captio
(c) Dukas -
DUK10163088_002
Hielt ihre Beschwerden für Covid: Bei der 27jährigen Evgenia aus London wurde eine aggressive Krebsart diagnostiziert
SONDERKONDITIONEN: Satzpreis!
WORDS BYLINE: Deborah Cicurel
For months, she brushed off the symptoms. The nagging pain in her shoulder blade, an irritating cough, and relentless fatigue all seemed like nothing serious.
But when Evgenia’s pain worsened, her energy drained, and a mysterious rash appeared, she knew something wasn’t right.
“I didn't really think that anything was going wrong until I really started feeling the pain in the shoulder blade getting more and more intense,” the 27-year-old says.
“I started coughing at some point as well, and this is when I thought maybe I’d got Covid. I didn't really pay much attention to it.
“Then it started getting really bad and I wouldn't be able to speak. I would cough all the time, and it really interfered with my day-to-day stuff.”
In March 2023 she decided to seek help. At first, doctors were unconcerned. An MRI of her neck revealed nothing alarming - except, by sheer luck, a small glimpse of a lump lower in her chest.
Evgenia, 25 at the time, was referred to a lung specialist but the appointment was delayed. Precious weeks ticked by before she could get further tests.
By the time she underwent a biopsy in July, her condition had deteriorated significantly.
The persistent cough made speaking difficult, everyday tasks left her exhausted, and what had started as a vague discomfort had become an overwhelming burden.
Then came the words no one ever expects to hear: Stage 4 lymphoma.
“I had a feeling before that I might have cancer,” Evgenia, from London, remembers. “I think actually knowing the diagnosis is much better than not knowing it.
“Of course I was upset and I couldn't believe the diagnosis for a bit, and I was like, ‘This cannot be happening to me. Why me?’
“But in a way it was a relief: when you don't know your diagnosis yet, you feel super frustrated because you know that you are getting worse and worse every day.
“And then when I finally found out the diagnosis, things started h *** Local Captio
(c) Dukas -
DUK10163088_010
Hielt ihre Beschwerden für Covid: Bei der 27jährigen Evgenia aus London wurde eine aggressive Krebsart diagnostiziert
SONDERKONDITIONEN: Satzpreis!
WORDS BYLINE: Deborah Cicurel
For months, she brushed off the symptoms. The nagging pain in her shoulder blade, an irritating cough, and relentless fatigue all seemed like nothing serious.
But when Evgenia’s pain worsened, her energy drained, and a mysterious rash appeared, she knew something wasn’t right.
“I didn't really think that anything was going wrong until I really started feeling the pain in the shoulder blade getting more and more intense,” the 27-year-old says.
“I started coughing at some point as well, and this is when I thought maybe I’d got Covid. I didn't really pay much attention to it.
“Then it started getting really bad and I wouldn't be able to speak. I would cough all the time, and it really interfered with my day-to-day stuff.”
In March 2023 she decided to seek help. At first, doctors were unconcerned. An MRI of her neck revealed nothing alarming - except, by sheer luck, a small glimpse of a lump lower in her chest.
Evgenia, 25 at the time, was referred to a lung specialist but the appointment was delayed. Precious weeks ticked by before she could get further tests.
By the time she underwent a biopsy in July, her condition had deteriorated significantly.
The persistent cough made speaking difficult, everyday tasks left her exhausted, and what had started as a vague discomfort had become an overwhelming burden.
Then came the words no one ever expects to hear: Stage 4 lymphoma.
“I had a feeling before that I might have cancer,” Evgenia, from London, remembers. “I think actually knowing the diagnosis is much better than not knowing it.
“Of course I was upset and I couldn't believe the diagnosis for a bit, and I was like, ‘This cannot be happening to me. Why me?’
“But in a way it was a relief: when you don't know your diagnosis yet, you feel super frustrated because you know that you are getting worse and worse every day.
“And then when I finally found out the diagnosis, things started h *** Local Captio
(c) Dukas -
DUK10163037_007
Aus Forschung und Wissenschaft: An der Northwestern University in Illinois wurde der kleinste Herzschrittmacher der Welt für die empfindlichen Herzen von Neugeborenen mit angeborenen Herzfehlern entwickelt
SONDERKONDITIONEN: Satzpreis!
**VIDEO AVAILABLE: CONTACT INFO@COVERMG.COM TO RECEIVE**
Engineers at Northwestern University in Illinois have developed an ultra-small pacemaker that can be non-invasively injected into the body via a syringe.
Although capable of functioning with hearts of all sizes, the pacemaker is particularly suited to the delicate hearts of newborns with congenital heart defects.
Measuring smaller than a single grain of rice, the pacemaker is designed to work alongside a small, soft, wireless, wearable device that attaches to a patient’s chest. When an irregular heartbeat is detected, the wearable device emits a pulse of light to activate the pacemaker. These pulses penetrate the skin, breastbone and muscles to regulate the heart’s rhythm.
Designed for temporary use, the pacemaker dissolves naturally once it is no longer required. As all components are biocompatible, they break down harmlessly in the body, eliminating the need for surgical removal.
The findings were published today in the journal Nature. The study demonstrated the device’s effectiveness across large and small animal models, as well as in human hearts from deceased organ donors.
Professor John A. Rogers, a leading expert in bioelectronics at Northwestern, led the development of the device.
“To our knowledge, this is the world’s smallest pacemaker,” he said. “Temporary pacemakers are crucial in paediatric heart surgeries, and miniaturisation is essential in reducing the burden on the body.”
Professor Igor Efimov, an experimental cardiologist who co-led the study, highlighted the motivation behind the work. “Around 1% of children are born with congenital heart defects, and many only require temporary pacing after surgery. Most hearts self-repair within a week, but that short period is critical. With this tiny pacemaker, we can provide essential support without additional surgery to remove it.”
Professor Rogers and Professor Efimov collaborated with colleagues at *** Local
(c) Dukas -
DUK10163037_005
Aus Forschung und Wissenschaft: An der Northwestern University in Illinois wurde der kleinste Herzschrittmacher der Welt für die empfindlichen Herzen von Neugeborenen mit angeborenen Herzfehlern entwickelt
SONDERKONDITIONEN: Satzpreis!
**VIDEO AVAILABLE: CONTACT INFO@COVERMG.COM TO RECEIVE**
Engineers at Northwestern University in Illinois have developed an ultra-small pacemaker that can be non-invasively injected into the body via a syringe.
Although capable of functioning with hearts of all sizes, the pacemaker is particularly suited to the delicate hearts of newborns with congenital heart defects.
Measuring smaller than a single grain of rice, the pacemaker is designed to work alongside a small, soft, wireless, wearable device that attaches to a patient’s chest. When an irregular heartbeat is detected, the wearable device emits a pulse of light to activate the pacemaker. These pulses penetrate the skin, breastbone and muscles to regulate the heart’s rhythm.
Designed for temporary use, the pacemaker dissolves naturally once it is no longer required. As all components are biocompatible, they break down harmlessly in the body, eliminating the need for surgical removal.
The findings were published today in the journal Nature. The study demonstrated the device’s effectiveness across large and small animal models, as well as in human hearts from deceased organ donors.
Professor John A. Rogers, a leading expert in bioelectronics at Northwestern, led the development of the device.
“To our knowledge, this is the world’s smallest pacemaker,” he said. “Temporary pacemakers are crucial in paediatric heart surgeries, and miniaturisation is essential in reducing the burden on the body.”
Professor Igor Efimov, an experimental cardiologist who co-led the study, highlighted the motivation behind the work. “Around 1% of children are born with congenital heart defects, and many only require temporary pacing after surgery. Most hearts self-repair within a week, but that short period is critical. With this tiny pacemaker, we can provide essential support without additional surgery to remove it.”
Professor Rogers and Professor Efimov collaborated with colleagues at *** Local
(c) Dukas -
DUK10163037_017
Aus Forschung und Wissenschaft: An der Northwestern University in Illinois wurde der kleinste Herzschrittmacher der Welt für die empfindlichen Herzen von Neugeborenen mit angeborenen Herzfehlern entwickelt
SONDERKONDITIONEN: Satzpreis!
**VIDEO AVAILABLE: CONTACT INFO@COVERMG.COM TO RECEIVE**
Engineers at Northwestern University in Illinois have developed an ultra-small pacemaker that can be non-invasively injected into the body via a syringe.
Although capable of functioning with hearts of all sizes, the pacemaker is particularly suited to the delicate hearts of newborns with congenital heart defects.
Measuring smaller than a single grain of rice, the pacemaker is designed to work alongside a small, soft, wireless, wearable device that attaches to a patient’s chest. When an irregular heartbeat is detected, the wearable device emits a pulse of light to activate the pacemaker. These pulses penetrate the skin, breastbone and muscles to regulate the heart’s rhythm.
Designed for temporary use, the pacemaker dissolves naturally once it is no longer required. As all components are biocompatible, they break down harmlessly in the body, eliminating the need for surgical removal.
The findings were published today in the journal Nature. The study demonstrated the device’s effectiveness across large and small animal models, as well as in human hearts from deceased organ donors.
Professor John A. Rogers, a leading expert in bioelectronics at Northwestern, led the development of the device.
“To our knowledge, this is the world’s smallest pacemaker,” he said. “Temporary pacemakers are crucial in paediatric heart surgeries, and miniaturisation is essential in reducing the burden on the body.”
Professor Igor Efimov, an experimental cardiologist who co-led the study, highlighted the motivation behind the work. “Around 1% of children are born with congenital heart defects, and many only require temporary pacing after surgery. Most hearts self-repair within a week, but that short period is critical. With this tiny pacemaker, we can provide essential support without additional surgery to remove it.”
Professor Rogers and Professor Efimov collaborated with colleagues at *** Local
(c) Dukas -
DUK10163037_002
Aus Forschung und Wissenschaft: An der Northwestern University in Illinois wurde der kleinste Herzschrittmacher der Welt für die empfindlichen Herzen von Neugeborenen mit angeborenen Herzfehlern entwickelt
SONDERKONDITIONEN: Satzpreis!
**VIDEO AVAILABLE: CONTACT INFO@COVERMG.COM TO RECEIVE**
Engineers at Northwestern University in Illinois have developed an ultra-small pacemaker that can be non-invasively injected into the body via a syringe.
Although capable of functioning with hearts of all sizes, the pacemaker is particularly suited to the delicate hearts of newborns with congenital heart defects.
Measuring smaller than a single grain of rice, the pacemaker is designed to work alongside a small, soft, wireless, wearable device that attaches to a patient’s chest. When an irregular heartbeat is detected, the wearable device emits a pulse of light to activate the pacemaker. These pulses penetrate the skin, breastbone and muscles to regulate the heart’s rhythm.
Designed for temporary use, the pacemaker dissolves naturally once it is no longer required. As all components are biocompatible, they break down harmlessly in the body, eliminating the need for surgical removal.
The findings were published today in the journal Nature. The study demonstrated the device’s effectiveness across large and small animal models, as well as in human hearts from deceased organ donors.
Professor John A. Rogers, a leading expert in bioelectronics at Northwestern, led the development of the device.
“To our knowledge, this is the world’s smallest pacemaker,” he said. “Temporary pacemakers are crucial in paediatric heart surgeries, and miniaturisation is essential in reducing the burden on the body.”
Professor Igor Efimov, an experimental cardiologist who co-led the study, highlighted the motivation behind the work. “Around 1% of children are born with congenital heart defects, and many only require temporary pacing after surgery. Most hearts self-repair within a week, but that short period is critical. With this tiny pacemaker, we can provide essential support without additional surgery to remove it.”
Professor Rogers and Professor Efimov collaborated with colleagues at *** Local
(c) Dukas -
DUK10163037_011
Aus Forschung und Wissenschaft: An der Northwestern University in Illinois wurde der kleinste Herzschrittmacher der Welt für die empfindlichen Herzen von Neugeborenen mit angeborenen Herzfehlern entwickelt
SONDERKONDITIONEN: Satzpreis!
**VIDEO AVAILABLE: CONTACT INFO@COVERMG.COM TO RECEIVE**
Engineers at Northwestern University in Illinois have developed an ultra-small pacemaker that can be non-invasively injected into the body via a syringe.
Although capable of functioning with hearts of all sizes, the pacemaker is particularly suited to the delicate hearts of newborns with congenital heart defects.
Measuring smaller than a single grain of rice, the pacemaker is designed to work alongside a small, soft, wireless, wearable device that attaches to a patient’s chest. When an irregular heartbeat is detected, the wearable device emits a pulse of light to activate the pacemaker. These pulses penetrate the skin, breastbone and muscles to regulate the heart’s rhythm.
Designed for temporary use, the pacemaker dissolves naturally once it is no longer required. As all components are biocompatible, they break down harmlessly in the body, eliminating the need for surgical removal.
The findings were published today in the journal Nature. The study demonstrated the device’s effectiveness across large and small animal models, as well as in human hearts from deceased organ donors.
Professor John A. Rogers, a leading expert in bioelectronics at Northwestern, led the development of the device.
“To our knowledge, this is the world’s smallest pacemaker,” he said. “Temporary pacemakers are crucial in paediatric heart surgeries, and miniaturisation is essential in reducing the burden on the body.”
Professor Igor Efimov, an experimental cardiologist who co-led the study, highlighted the motivation behind the work. “Around 1% of children are born with congenital heart defects, and many only require temporary pacing after surgery. Most hearts self-repair within a week, but that short period is critical. With this tiny pacemaker, we can provide essential support without additional surgery to remove it.”
Professor Rogers and Professor Efimov collaborated with colleagues at *** Local
(c) Dukas -
DUK10163037_012
Aus Forschung und Wissenschaft: An der Northwestern University in Illinois wurde der kleinste Herzschrittmacher der Welt für die empfindlichen Herzen von Neugeborenen mit angeborenen Herzfehlern entwickelt
SONDERKONDITIONEN: Satzpreis!
**VIDEO AVAILABLE: CONTACT INFO@COVERMG.COM TO RECEIVE**
Engineers at Northwestern University in Illinois have developed an ultra-small pacemaker that can be non-invasively injected into the body via a syringe.
Although capable of functioning with hearts of all sizes, the pacemaker is particularly suited to the delicate hearts of newborns with congenital heart defects.
Measuring smaller than a single grain of rice, the pacemaker is designed to work alongside a small, soft, wireless, wearable device that attaches to a patient’s chest. When an irregular heartbeat is detected, the wearable device emits a pulse of light to activate the pacemaker. These pulses penetrate the skin, breastbone and muscles to regulate the heart’s rhythm.
Designed for temporary use, the pacemaker dissolves naturally once it is no longer required. As all components are biocompatible, they break down harmlessly in the body, eliminating the need for surgical removal.
The findings were published today in the journal Nature. The study demonstrated the device’s effectiveness across large and small animal models, as well as in human hearts from deceased organ donors.
Professor John A. Rogers, a leading expert in bioelectronics at Northwestern, led the development of the device.
“To our knowledge, this is the world’s smallest pacemaker,” he said. “Temporary pacemakers are crucial in paediatric heart surgeries, and miniaturisation is essential in reducing the burden on the body.”
Professor Igor Efimov, an experimental cardiologist who co-led the study, highlighted the motivation behind the work. “Around 1% of children are born with congenital heart defects, and many only require temporary pacing after surgery. Most hearts self-repair within a week, but that short period is critical. With this tiny pacemaker, we can provide essential support without additional surgery to remove it.”
Professor Rogers and Professor Efimov collaborated with colleagues at *** Local
(c) Dukas -
DUK10163037_004
Aus Forschung und Wissenschaft: An der Northwestern University in Illinois wurde der kleinste Herzschrittmacher der Welt für die empfindlichen Herzen von Neugeborenen mit angeborenen Herzfehlern entwickelt
SONDERKONDITIONEN: Satzpreis!
**VIDEO AVAILABLE: CONTACT INFO@COVERMG.COM TO RECEIVE**
Engineers at Northwestern University in Illinois have developed an ultra-small pacemaker that can be non-invasively injected into the body via a syringe.
Although capable of functioning with hearts of all sizes, the pacemaker is particularly suited to the delicate hearts of newborns with congenital heart defects.
Measuring smaller than a single grain of rice, the pacemaker is designed to work alongside a small, soft, wireless, wearable device that attaches to a patient’s chest. When an irregular heartbeat is detected, the wearable device emits a pulse of light to activate the pacemaker. These pulses penetrate the skin, breastbone and muscles to regulate the heart’s rhythm.
Designed for temporary use, the pacemaker dissolves naturally once it is no longer required. As all components are biocompatible, they break down harmlessly in the body, eliminating the need for surgical removal.
The findings were published today in the journal Nature. The study demonstrated the device’s effectiveness across large and small animal models, as well as in human hearts from deceased organ donors.
Professor John A. Rogers, a leading expert in bioelectronics at Northwestern, led the development of the device.
“To our knowledge, this is the world’s smallest pacemaker,” he said. “Temporary pacemakers are crucial in paediatric heart surgeries, and miniaturisation is essential in reducing the burden on the body.”
Professor Igor Efimov, an experimental cardiologist who co-led the study, highlighted the motivation behind the work. “Around 1% of children are born with congenital heart defects, and many only require temporary pacing after surgery. Most hearts self-repair within a week, but that short period is critical. With this tiny pacemaker, we can provide essential support without additional surgery to remove it.”
Professor Rogers and Professor Efimov collaborated with colleagues at *** Local
(c) Dukas -
DUK10163037_016
Aus Forschung und Wissenschaft: An der Northwestern University in Illinois wurde der kleinste Herzschrittmacher der Welt für die empfindlichen Herzen von Neugeborenen mit angeborenen Herzfehlern entwickelt
SONDERKONDITIONEN: Satzpreis!
**VIDEO AVAILABLE: CONTACT INFO@COVERMG.COM TO RECEIVE**
Engineers at Northwestern University in Illinois have developed an ultra-small pacemaker that can be non-invasively injected into the body via a syringe.
Although capable of functioning with hearts of all sizes, the pacemaker is particularly suited to the delicate hearts of newborns with congenital heart defects.
Measuring smaller than a single grain of rice, the pacemaker is designed to work alongside a small, soft, wireless, wearable device that attaches to a patient’s chest. When an irregular heartbeat is detected, the wearable device emits a pulse of light to activate the pacemaker. These pulses penetrate the skin, breastbone and muscles to regulate the heart’s rhythm.
Designed for temporary use, the pacemaker dissolves naturally once it is no longer required. As all components are biocompatible, they break down harmlessly in the body, eliminating the need for surgical removal.
The findings were published today in the journal Nature. The study demonstrated the device’s effectiveness across large and small animal models, as well as in human hearts from deceased organ donors.
Professor John A. Rogers, a leading expert in bioelectronics at Northwestern, led the development of the device.
“To our knowledge, this is the world’s smallest pacemaker,” he said. “Temporary pacemakers are crucial in paediatric heart surgeries, and miniaturisation is essential in reducing the burden on the body.”
Professor Igor Efimov, an experimental cardiologist who co-led the study, highlighted the motivation behind the work. “Around 1% of children are born with congenital heart defects, and many only require temporary pacing after surgery. Most hearts self-repair within a week, but that short period is critical. With this tiny pacemaker, we can provide essential support without additional surgery to remove it.”
Professor Rogers and Professor Efimov collaborated with colleagues at *** Local
(c) Dukas -
DUK10163037_013
Aus Forschung und Wissenschaft: An der Northwestern University in Illinois wurde der kleinste Herzschrittmacher der Welt für die empfindlichen Herzen von Neugeborenen mit angeborenen Herzfehlern entwickelt
SONDERKONDITIONEN: Satzpreis!
**VIDEO AVAILABLE: CONTACT INFO@COVERMG.COM TO RECEIVE**
Engineers at Northwestern University in Illinois have developed an ultra-small pacemaker that can be non-invasively injected into the body via a syringe.
Although capable of functioning with hearts of all sizes, the pacemaker is particularly suited to the delicate hearts of newborns with congenital heart defects.
Measuring smaller than a single grain of rice, the pacemaker is designed to work alongside a small, soft, wireless, wearable device that attaches to a patient’s chest. When an irregular heartbeat is detected, the wearable device emits a pulse of light to activate the pacemaker. These pulses penetrate the skin, breastbone and muscles to regulate the heart’s rhythm.
Designed for temporary use, the pacemaker dissolves naturally once it is no longer required. As all components are biocompatible, they break down harmlessly in the body, eliminating the need for surgical removal.
The findings were published today in the journal Nature. The study demonstrated the device’s effectiveness across large and small animal models, as well as in human hearts from deceased organ donors.
Professor John A. Rogers, a leading expert in bioelectronics at Northwestern, led the development of the device.
“To our knowledge, this is the world’s smallest pacemaker,” he said. “Temporary pacemakers are crucial in paediatric heart surgeries, and miniaturisation is essential in reducing the burden on the body.”
Professor Igor Efimov, an experimental cardiologist who co-led the study, highlighted the motivation behind the work. “Around 1% of children are born with congenital heart defects, and many only require temporary pacing after surgery. Most hearts self-repair within a week, but that short period is critical. With this tiny pacemaker, we can provide essential support without additional surgery to remove it.”
Professor Rogers and Professor Efimov collaborated with colleagues at *** Local
(c) Dukas -
DUK10163037_006
Aus Forschung und Wissenschaft: An der Northwestern University in Illinois wurde der kleinste Herzschrittmacher der Welt für die empfindlichen Herzen von Neugeborenen mit angeborenen Herzfehlern entwickelt
SONDERKONDITIONEN: Satzpreis!
**VIDEO AVAILABLE: CONTACT INFO@COVERMG.COM TO RECEIVE**
Engineers at Northwestern University in Illinois have developed an ultra-small pacemaker that can be non-invasively injected into the body via a syringe.
Although capable of functioning with hearts of all sizes, the pacemaker is particularly suited to the delicate hearts of newborns with congenital heart defects.
Measuring smaller than a single grain of rice, the pacemaker is designed to work alongside a small, soft, wireless, wearable device that attaches to a patient’s chest. When an irregular heartbeat is detected, the wearable device emits a pulse of light to activate the pacemaker. These pulses penetrate the skin, breastbone and muscles to regulate the heart’s rhythm.
Designed for temporary use, the pacemaker dissolves naturally once it is no longer required. As all components are biocompatible, they break down harmlessly in the body, eliminating the need for surgical removal.
The findings were published today in the journal Nature. The study demonstrated the device’s effectiveness across large and small animal models, as well as in human hearts from deceased organ donors.
Professor John A. Rogers, a leading expert in bioelectronics at Northwestern, led the development of the device.
“To our knowledge, this is the world’s smallest pacemaker,” he said. “Temporary pacemakers are crucial in paediatric heart surgeries, and miniaturisation is essential in reducing the burden on the body.”
Professor Igor Efimov, an experimental cardiologist who co-led the study, highlighted the motivation behind the work. “Around 1% of children are born with congenital heart defects, and many only require temporary pacing after surgery. Most hearts self-repair within a week, but that short period is critical. With this tiny pacemaker, we can provide essential support without additional surgery to remove it.”
Professor Rogers and Professor Efimov collaborated with colleagues at *** Local
(c) Dukas -
DUK10163037_009
Aus Forschung und Wissenschaft: An der Northwestern University in Illinois wurde der kleinste Herzschrittmacher der Welt für die empfindlichen Herzen von Neugeborenen mit angeborenen Herzfehlern entwickelt
SONDERKONDITIONEN: Satzpreis!
**VIDEO AVAILABLE: CONTACT INFO@COVERMG.COM TO RECEIVE**
Engineers at Northwestern University in Illinois have developed an ultra-small pacemaker that can be non-invasively injected into the body via a syringe.
Although capable of functioning with hearts of all sizes, the pacemaker is particularly suited to the delicate hearts of newborns with congenital heart defects.
Measuring smaller than a single grain of rice, the pacemaker is designed to work alongside a small, soft, wireless, wearable device that attaches to a patient’s chest. When an irregular heartbeat is detected, the wearable device emits a pulse of light to activate the pacemaker. These pulses penetrate the skin, breastbone and muscles to regulate the heart’s rhythm.
Designed for temporary use, the pacemaker dissolves naturally once it is no longer required. As all components are biocompatible, they break down harmlessly in the body, eliminating the need for surgical removal.
The findings were published today in the journal Nature. The study demonstrated the device’s effectiveness across large and small animal models, as well as in human hearts from deceased organ donors.
Professor John A. Rogers, a leading expert in bioelectronics at Northwestern, led the development of the device.
“To our knowledge, this is the world’s smallest pacemaker,” he said. “Temporary pacemakers are crucial in paediatric heart surgeries, and miniaturisation is essential in reducing the burden on the body.”
Professor Igor Efimov, an experimental cardiologist who co-led the study, highlighted the motivation behind the work. “Around 1% of children are born with congenital heart defects, and many only require temporary pacing after surgery. Most hearts self-repair within a week, but that short period is critical. With this tiny pacemaker, we can provide essential support without additional surgery to remove it.”
Professor Rogers and Professor Efimov collaborated with colleagues at *** Local
(c) Dukas -
DUK10163037_001
Aus Forschung und Wissenschaft: An der Northwestern University in Illinois wurde der kleinste Herzschrittmacher der Welt für die empfindlichen Herzen von Neugeborenen mit angeborenen Herzfehlern entwickelt
SONDERKONDITIONEN: Satzpreis!
**VIDEO AVAILABLE: CONTACT INFO@COVERMG.COM TO RECEIVE**
Engineers at Northwestern University in Illinois have developed an ultra-small pacemaker that can be non-invasively injected into the body via a syringe.
Although capable of functioning with hearts of all sizes, the pacemaker is particularly suited to the delicate hearts of newborns with congenital heart defects.
Measuring smaller than a single grain of rice, the pacemaker is designed to work alongside a small, soft, wireless, wearable device that attaches to a patient’s chest. When an irregular heartbeat is detected, the wearable device emits a pulse of light to activate the pacemaker. These pulses penetrate the skin, breastbone and muscles to regulate the heart’s rhythm.
Designed for temporary use, the pacemaker dissolves naturally once it is no longer required. As all components are biocompatible, they break down harmlessly in the body, eliminating the need for surgical removal.
The findings were published today in the journal Nature. The study demonstrated the device’s effectiveness across large and small animal models, as well as in human hearts from deceased organ donors.
Professor John A. Rogers, a leading expert in bioelectronics at Northwestern, led the development of the device.
“To our knowledge, this is the world’s smallest pacemaker,” he said. “Temporary pacemakers are crucial in paediatric heart surgeries, and miniaturisation is essential in reducing the burden on the body.”
Professor Igor Efimov, an experimental cardiologist who co-led the study, highlighted the motivation behind the work. “Around 1% of children are born with congenital heart defects, and many only require temporary pacing after surgery. Most hearts self-repair within a week, but that short period is critical. With this tiny pacemaker, we can provide essential support without additional surgery to remove it.”
Professor Rogers and Professor Efimov collaborated with colleagues at *** Local
(c) Dukas -
DUK10163037_015
Aus Forschung und Wissenschaft: An der Northwestern University in Illinois wurde der kleinste Herzschrittmacher der Welt für die empfindlichen Herzen von Neugeborenen mit angeborenen Herzfehlern entwickelt
SONDERKONDITIONEN: Satzpreis!
**VIDEO AVAILABLE: CONTACT INFO@COVERMG.COM TO RECEIVE**
Engineers at Northwestern University in Illinois have developed an ultra-small pacemaker that can be non-invasively injected into the body via a syringe.
Although capable of functioning with hearts of all sizes, the pacemaker is particularly suited to the delicate hearts of newborns with congenital heart defects.
Measuring smaller than a single grain of rice, the pacemaker is designed to work alongside a small, soft, wireless, wearable device that attaches to a patient’s chest. When an irregular heartbeat is detected, the wearable device emits a pulse of light to activate the pacemaker. These pulses penetrate the skin, breastbone and muscles to regulate the heart’s rhythm.
Designed for temporary use, the pacemaker dissolves naturally once it is no longer required. As all components are biocompatible, they break down harmlessly in the body, eliminating the need for surgical removal.
The findings were published today in the journal Nature. The study demonstrated the device’s effectiveness across large and small animal models, as well as in human hearts from deceased organ donors.
Professor John A. Rogers, a leading expert in bioelectronics at Northwestern, led the development of the device.
“To our knowledge, this is the world’s smallest pacemaker,” he said. “Temporary pacemakers are crucial in paediatric heart surgeries, and miniaturisation is essential in reducing the burden on the body.”
Professor Igor Efimov, an experimental cardiologist who co-led the study, highlighted the motivation behind the work. “Around 1% of children are born with congenital heart defects, and many only require temporary pacing after surgery. Most hearts self-repair within a week, but that short period is critical. With this tiny pacemaker, we can provide essential support without additional surgery to remove it.”
Professor Rogers and Professor Efimov collaborated with colleagues at *** Local
(c) Dukas -
DUK10163037_014
Aus Forschung und Wissenschaft: An der Northwestern University in Illinois wurde der kleinste Herzschrittmacher der Welt für die empfindlichen Herzen von Neugeborenen mit angeborenen Herzfehlern entwickelt
SONDERKONDITIONEN: Satzpreis!
**VIDEO AVAILABLE: CONTACT INFO@COVERMG.COM TO RECEIVE**
Engineers at Northwestern University in Illinois have developed an ultra-small pacemaker that can be non-invasively injected into the body via a syringe.
Although capable of functioning with hearts of all sizes, the pacemaker is particularly suited to the delicate hearts of newborns with congenital heart defects.
Measuring smaller than a single grain of rice, the pacemaker is designed to work alongside a small, soft, wireless, wearable device that attaches to a patient’s chest. When an irregular heartbeat is detected, the wearable device emits a pulse of light to activate the pacemaker. These pulses penetrate the skin, breastbone and muscles to regulate the heart’s rhythm.
Designed for temporary use, the pacemaker dissolves naturally once it is no longer required. As all components are biocompatible, they break down harmlessly in the body, eliminating the need for surgical removal.
The findings were published today in the journal Nature. The study demonstrated the device’s effectiveness across large and small animal models, as well as in human hearts from deceased organ donors.
Professor John A. Rogers, a leading expert in bioelectronics at Northwestern, led the development of the device.
“To our knowledge, this is the world’s smallest pacemaker,” he said. “Temporary pacemakers are crucial in paediatric heart surgeries, and miniaturisation is essential in reducing the burden on the body.”
Professor Igor Efimov, an experimental cardiologist who co-led the study, highlighted the motivation behind the work. “Around 1% of children are born with congenital heart defects, and many only require temporary pacing after surgery. Most hearts self-repair within a week, but that short period is critical. With this tiny pacemaker, we can provide essential support without additional surgery to remove it.”
Professor Rogers and Professor Efimov collaborated with colleagues at *** Local
(c) Dukas -
DUK10163037_010
Aus Forschung und Wissenschaft: An der Northwestern University in Illinois wurde der kleinste Herzschrittmacher der Welt für die empfindlichen Herzen von Neugeborenen mit angeborenen Herzfehlern entwickelt
SONDERKONDITIONEN: Satzpreis!
**VIDEO AVAILABLE: CONTACT INFO@COVERMG.COM TO RECEIVE**
Engineers at Northwestern University in Illinois have developed an ultra-small pacemaker that can be non-invasively injected into the body via a syringe.
Although capable of functioning with hearts of all sizes, the pacemaker is particularly suited to the delicate hearts of newborns with congenital heart defects.
Measuring smaller than a single grain of rice, the pacemaker is designed to work alongside a small, soft, wireless, wearable device that attaches to a patient’s chest. When an irregular heartbeat is detected, the wearable device emits a pulse of light to activate the pacemaker. These pulses penetrate the skin, breastbone and muscles to regulate the heart’s rhythm.
Designed for temporary use, the pacemaker dissolves naturally once it is no longer required. As all components are biocompatible, they break down harmlessly in the body, eliminating the need for surgical removal.
The findings were published today in the journal Nature. The study demonstrated the device’s effectiveness across large and small animal models, as well as in human hearts from deceased organ donors.
Professor John A. Rogers, a leading expert in bioelectronics at Northwestern, led the development of the device.
“To our knowledge, this is the world’s smallest pacemaker,” he said. “Temporary pacemakers are crucial in paediatric heart surgeries, and miniaturisation is essential in reducing the burden on the body.”
Professor Igor Efimov, an experimental cardiologist who co-led the study, highlighted the motivation behind the work. “Around 1% of children are born with congenital heart defects, and many only require temporary pacing after surgery. Most hearts self-repair within a week, but that short period is critical. With this tiny pacemaker, we can provide essential support without additional surgery to remove it.”
Professor Rogers and Professor Efimov collaborated with colleagues at *** Local
(c) Dukas -
DUK10163037_003
Aus Forschung und Wissenschaft: An der Northwestern University in Illinois wurde der kleinste Herzschrittmacher der Welt für die empfindlichen Herzen von Neugeborenen mit angeborenen Herzfehlern entwickelt
SONDERKONDITIONEN: Satzpreis!
**VIDEO AVAILABLE: CONTACT INFO@COVERMG.COM TO RECEIVE**
Engineers at Northwestern University in Illinois have developed an ultra-small pacemaker that can be non-invasively injected into the body via a syringe.
Although capable of functioning with hearts of all sizes, the pacemaker is particularly suited to the delicate hearts of newborns with congenital heart defects.
Measuring smaller than a single grain of rice, the pacemaker is designed to work alongside a small, soft, wireless, wearable device that attaches to a patient’s chest. When an irregular heartbeat is detected, the wearable device emits a pulse of light to activate the pacemaker. These pulses penetrate the skin, breastbone and muscles to regulate the heart’s rhythm.
Designed for temporary use, the pacemaker dissolves naturally once it is no longer required. As all components are biocompatible, they break down harmlessly in the body, eliminating the need for surgical removal.
The findings were published today in the journal Nature. The study demonstrated the device’s effectiveness across large and small animal models, as well as in human hearts from deceased organ donors.
Professor John A. Rogers, a leading expert in bioelectronics at Northwestern, led the development of the device.
“To our knowledge, this is the world’s smallest pacemaker,” he said. “Temporary pacemakers are crucial in paediatric heart surgeries, and miniaturisation is essential in reducing the burden on the body.”
Professor Igor Efimov, an experimental cardiologist who co-led the study, highlighted the motivation behind the work. “Around 1% of children are born with congenital heart defects, and many only require temporary pacing after surgery. Most hearts self-repair within a week, but that short period is critical. With this tiny pacemaker, we can provide essential support without additional surgery to remove it.”
Professor Rogers and Professor Efimov collaborated with colleagues at *** Local
(c) Dukas -
